Pharmaceutical News

RSS

Tiny medical device containing gold specks could boost effects of cancer drugs

A tiny medical device containing gold specks could boost the effects of cancer medication and reduce its harm, research suggests.

7 Aug 2017

Proton pump inhibitor use not linked to increased risk of Alzheimer's disease

The use of proton pump inhibitors does not increase the risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland.

7 Aug 2017

Study develops correction methods to provide more accurate estimates of opioid, heroin deaths

Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings.

7 Aug 2017

Compound derived from cannabis may alter blood levels of antiepileptic drugs

New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.

7 Aug 2017

Opioid prescription use found to be more common among cancer survivors

A new study found that opioid prescription use is more common in cancer survivors than in individuals without a history of cancer.

7 Aug 2017

New method for evaluating drug safety can detect stress on cells at earlier stages

A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death.

4 Aug 2017

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.

4 Aug 2017

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.

4 Aug 2017

Researchers explore why physicians underprescribe drug approved to treat opioid addiction

A drug approved for private physicians to treat opioid addiction is being underprescribed, and a survey of addiction specialists suggests that many of them are not willing to increase their use of it, despite an expanding opioid addiction epidemic in the United States, according to research presented at the 125th Annual Convention of the American Psychological Association.

4 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

HIV prevention drug to be trialed by Britain's NHS

After a High Court case, an HIV prevention drug is soon to be available on the NHS. NHS England has issued a statement saying that pre-exposure prophylaxis (PrEP) treatment for HIV shall be available to an initial 10,000 people for a trial period of three years.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

Study findings could lead to more effective and faster acting antidepressants

For people suffering from depression, a day without treatment can seem like a lifetime. A new study explains why the most commonly prescribed antidepressants can take as long as six weeks to have an effect. The findings could one day lead to more effective and faster acting drugs.

3 Aug 2017

Study finds high rates of drug resistance to urinary tract infections in Bangladesh

Organisms causing urinary tract infections (UTI) are increasingly proving to be ineffective or showing resistance to drugs that are used to kill the germs. This phenomenon has been increasing worldwide, especially to commonly used antimicrobials (drugs) in children.

3 Aug 2017

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

Common anti-allergy medicines could prove to be an effective treatment for potentially fatal blood clots in the legs, according to new research by the University of Birmingham.

2 Aug 2017

Researchers reveal prevalence of unused prescription opioids following surgery

In a review of half a dozen published studies in which patients self-reported use of opioids prescribed to them after surgery, researchers at Johns Hopkins report that a substantial majority of patients used only some or none of the pills, and more than 90 percent failed to dispose of the leftovers in recommended ways.

2 Aug 2017

Drug puts a $750,000 ‘price tag on life’

Jana Gundy and Amanda Chaffin live within two hours of each other in Oklahoma. Each has a child with the same devastating disease, one that robs them of muscle strength, affecting their ability to sit, stand or even breathe.

2 Aug 2017

Pharmaceutical News

Tiny medical device containing gold specks could boost effects of cancer drugs

Proton pump inhibitor use not linked to increased risk of Alzheimer's disease

Study develops correction methods to provide more accurate estimates of opioid, heroin deaths

Compound derived from cannabis may alter blood levels of antiepileptic drugs

Opioid prescription use found to be more common among cancer survivors

New method for evaluating drug safety can detect stress on cells at earlier stages

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Researchers explore why physicians underprescribe drug approved to treat opioid addiction

FDA approves new treatment for all HCV genotypes 1-6

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

HIV prevention drug to be trialed by Britain's NHS

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Study findings could lead to more effective and faster acting antidepressants

Study finds high rates of drug resistance to urinary tract infections in Bangladesh

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

Researchers reveal prevalence of unused prescription opioids following surgery

Drug puts a $750,000 ‘price tag on life’

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News